MRPL evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-23T14:00:22.887841+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 886674900000.0
- net_income
- 19245800000.0
- operating_cash_flow
- 18429600000.0
- free_cash_flow
- 4306900000.0
- total_assets
- 444812300000.0
- total_liabilities
- 302843600000.0
- total_equity
- 141968700000.0
- cash
- 6105900000.0
- total_debt
- 153410200000.0
- revenue_growth
- -0.06314229848097963
- earnings_growth
- 33.24214927497554
- net_margin
- 0.021705587921796367
- roe
- 0.13556368410783504
- debt_to_equity
- 1.080591707890542
- cash_conversion
- 0.9575907470720885
- free_cash_flow_margin
- 0.004857360910971992
- trailing_pe
- 9.1169
- forward_pe
- 15.9236
- peg_ratio
- Not supplied
- price_to_book
- 2.0173
- dividend_yield
- 0.0
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-aa8d55d6e7fdffa7e16f422e33675b2636e595bbddf0705aba711b6ecc9c8838
- Policy
- stock-decisions-v1
- Evidence bundle hash
- 10cc8ef1294691102acfc58a40ea850691fc32906917c71cbd232f97f4237142
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: fee62689b87584c46812126246bfcb362f4dde9bb331d7ed616c7ce6020f904a
- daily-price: 8de3f4bb07f96ff59abe47b6679645976f1f7e44261402f5549c5c260c561697
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: VERIFIED.
- The cached closing price on 2026-10-01 was INR 164.76.
- The trailing 5-session price return was 0.16%.
- The trailing 20-session price return was -5.97%.
- The trailing 60-session price return was 11.37%.
- The trailing 250-session price return was 32.06%.
- Average cached traded value over twenty sessions was INR 2,117,777,914.
- The closing price was -20.32% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-23T14:00:22.887841+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is -0.06314229848097963.
- The cached financial metric net margin is 0.021705587921796367.
- The cached financial metric roe is 0.13556368410783504.
- The cached financial metric debt to equity is 1.080591707890542.
- The cached financial metric cash conversion is 0.9575907470720885.
- The cached financial metric free cash flow margin is 0.004857360910971992.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.